Biopharmas in Asia-Pacific raising money in public or private financings, including: Adrenomed, Eluminex, Oragenics.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: AB Science, Abbreos, Allero, Alvotech, Arrowhead, Ascentage, Axon Neuroscience, Biovaxys Technology, Cedilla, Dr. Reddy’s, Egle, Eisai, Glenmark, Hitgen, Humanigen, Immuron, Jaguar Health, Medicinova, Merck KGaA, Neurorx, Oncosec Medical, Preveceutical Medical, Redhill, Relief, SAB, Scintec Diagnostics, Takeda, Telix, Therapharm, Viiv Healthcare, Vivacelle, Wren, Yangtze River.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aeglea, Amicus, Autobahn, Biontech, Bridgebio, Cerecor, Gilead, Incannex, Ipsen, Janssen-Cilag, Junshi, Merz, Minerva, Moderna, Moleculin, Pfizer, QED, Rhizen, Roche, Tearclear, TG, VBI.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abfero, Actavis, Adamis, Amarin, Anixa, Astrazeneca, Auris, Beigene, Bioclonetics, Biohaven, Casma, Cel-Sci, Chrysalis, Dragonfly, Elevar, Entheon, Enzolytics, ERS, Eversana, Grünenthal, Helsinn, Hikma, Horizon, Janssen, Kyowa Kirin, Luca, Macrogenics, Merck & Co., Newstem, Novelstem, Outlook Sanyou, Sesen, Sosei, Specifica, Sun, Tris, UCB, Vigeneron, Vipergen, Vivlion, Wuxi Apptec, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Agios, Allysta, Astrazeneca, Athira, Axsome, Beigene, Bellerophon, Celularity, Codagenix, Dr. Reddy's, Galapagos, Genprex, Histogen, Ionis, Junshi, Neurotherapia, Nordic, Phathom, Plus, Rafael, Regenxbio, Russian Direct Investment Fund, Therapeutics Solution, Travere, Vyne, Zymeworks.

Biopharmas raising money in public or private financings, including: Canbridge, Cogent, Hepion, ILC, Intellia, Lixte, Maat, Mannkind, Olix, Perseus Proteomics, Regulus, Sunshine, Tallac.

New hires and promotions in the biopharma industry, including: Achilles, Adicet, Allena, Antios, Arena, Avita, Briacell, Cellink, Cogent, Elevar, Engitix, Entera, Fibrogen, Mannkind, Matinas, Mersana, Novozymes, Praxis, Rentschler, Samumed, Zai.

Med-tech firms raising money in public or private financings, including: 908 Devices, Controlrad, Endomag.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cerus, Ortho Clinical Diagnostics, Profound Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Shape, Align Technology, Aurora Spine, Carmat, LGC Group, Luminultra, Maplight Therapeutics, Qiagen, Salient Bio, Solos Endoscopy, Source Molecular.